A patient with anaphylaxis remains hypotensive with persistent bronchospasm despite two correctly administered 500-microgram IM adrenaline doses, high-flow oxygen and an initial crystalloid bolus. A critical-care clinician with continuous monitoring is present. What is the preferred next adrenaline strategy?